131 related articles for article (PubMed ID: 479064)
1. Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency.
van Dalen R; Vree TB; Hafkenscheid JC; Gimbrère JS
J Antimicrob Chemother; 1979 May; 5(3):281-92. PubMed ID: 479064
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
[TBL] [Abstract][Full Text] [Related]
3. Effect of decreased renal function on the pharmacokinetics of ceftazidime.
Ackerman BH; Ross J; Tofte RW; Rotschafer JC
Antimicrob Agents Chemother; 1984 Jun; 25(6):785-6. PubMed ID: 6378087
[TBL] [Abstract][Full Text] [Related]
4. Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.
Czerwinski AW; Pederson JA; Barry JP
J Clin Pharmacol; 1974 Oct; 14(10):560-6. PubMed ID: 4430733
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.
Ohkawa M; Hirano S; Tokunaga S; Motoi I; Shoda R; Ikeda A; Sugata T; Sawaki M; Shimamura M; Okasho A; Kuroda K
Antimicrob Agents Chemother; 1983 Jan; 23(1):31-5. PubMed ID: 6572490
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of moxalactam in patients with renal insufficiency.
Lam M; Manion CV; Czerwinski AW
Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefamandole in patients with renal impairment.
Czerwinski AW; Pederson JA
Antimicrob Agents Chemother; 1979 Feb; 15(2):161-4. PubMed ID: 426510
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.
Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA
Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of cefpirome in patients with renal impairment.
Lameire N; Malerczyk V; Drees B; Lehr K; Rosenkranz B
Clin Pharmacol Ther; 1992 Jul; 52(1):24-30. PubMed ID: 1623690
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
Leroy A; Canonne MA; Fillastre JP; Humbert G
Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of ceftazidime in patients with renal insufficiency.
Welage LS; Schultz RW; Schentag JJ
Antimicrob Agents Chemother; 1984 Feb; 25(2):201-4. PubMed ID: 6370127
[TBL] [Abstract][Full Text] [Related]
12. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
Reutter F; Maurice NP
Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
[No Abstract] [Full Text] [Related]
13. Contribution to the pharmacokinetics of a new cephalosporin derivative.
Dvorácek K; Modr Z; Schmidt O; Necásková A
Arzneimittelforschung; 1974 Sep; 24(9b):1468-70. PubMed ID: 4479805
[No Abstract] [Full Text] [Related]
14. Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats.
Balant L; Dayer P; Rudhardt M; Allaz AF; Fabre J
Clin Ther; 1980; 3(Spec Issue):50-9. PubMed ID: 6446399
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.
Ohkawa M; Orito M; Sugata T; Shimamura M; Sawaki M; Nakashita E; Kuroda K; Sasahara K
Antimicrob Agents Chemother; 1980 Sep; 18(3):386-9. PubMed ID: 6932824
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of cefamandole in patients with reduced renal function.
Czerwinski AW; Pederson JA
Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of cefuroxime in the elderly.
Broekhuysen J; Deger F; Douchamps J; Freschi E; Mal N; Neve P; Parfait R; Siska G; Winand M
Br J Clin Pharmacol; 1981 Dec; 12(6):801-5. PubMed ID: 7340882
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefamandole in patients with normal and impaired renal function.
Mellin HE; Welling PG; Madsen PO
Antimicrob Agents Chemother; 1977 Feb; 11(2):262-6. PubMed ID: 848932
[TBL] [Abstract][Full Text] [Related]
19. Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction.
Krakamp B; Tanswell P; Vogel H; Bozler G
Eur J Clin Pharmacol; 1989; 36(1):75-8. PubMed ID: 2917593
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefroxadine in healthy volunteers and patients with impaired renal function.
Ohkawa M; Takamae K; Shimamura M; Kuroda K; Awazu S
Chemotherapy; 1981; 27(3):149-54. PubMed ID: 7226971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
